Nancy Cristina Ferraz de Lucena Ferreira

ORCID: 0000-0002-2299-1234
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Women's cancer prevention and management
  • Breast Cancer Treatment Studies
  • Breast Implant and Reconstruction
  • Breast Lesions and Carcinomas
  • Wnt/β-catenin signaling in development and cancer
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer-related gene regulation
  • Phagocytosis and Immune Regulation
  • HER2/EGFR in Cancer Research
  • AI in cancer detection
  • Lung Cancer Treatments and Mutations
  • Digital Imaging in Medicine
  • Cancer Risks and Factors
  • Chronic Lymphocytic Leukemia Research
  • Axon Guidance and Neuronal Signaling
  • Cancer Genomics and Diagnostics
  • Molecular Biology Techniques and Applications

Centro Universitário Barão de Mauá
2025

Universidade Federal de Pernambuco
2018-2022

Introduction: Breast reconstruction is a right guaranteed by the public health system to patients undergoing mastectomy. The present study aimed understand epidemiological profile of women with breast cancer who underwent at referral hospital in Northeast region Brazil. Methods: Observational, retrospective an analytical character and descriptive approach. Data were collected through sociodemographic questionnaire clinical-surgical history, subsequently analyzed using SPSS version 18,...

10.29289/2594539420240001 article EN Mastology 2025-02-25

Abstract Background Triple-negative breast cancer (TNBC) is a heterogenous subtype involving different patterns of behavior and clinical course, demanding complex, individualized sequence treatment. The knowledge attitudes the affiliated members Brazilian Society Mastology regarding TNBC were evaluated consensus management treatment was reached. Methods Affiliates completed survey 44 objective questions. In addition, specialist meeting held with 27 experts 3 ad hoc consultants. panelists...

10.1186/s12885-022-10250-x article EN cc-by BMC Cancer 2022-11-22

ABSTRACT Receptor tyrosine kinases (RTKs) are involved in cell growth, motility, and differentiation. Deregulation of RTKs signaling is associated with tumor development therapy resistance. Potential like TAM (TYRO3, AXL, MERTK), RON, EPH, MET have been evaluated many cancers lung, prostate, colorectal, but little known breast tumors. In this study, 51 luminal cancer tissue 8 triple negative (TNBC) subtypes were by qPCR for the expression , EPHA2 genes. Statistical analysis was performed to...

10.1002/cbf.4128 article EN Cell Biochemistry and Function 2024-09-26

Objective: This study evaluated the number of breast reconstructive surgeries performed in SUS, period from January 2019 to 2023, making a comparative analysis between mastectomies and reconstructions same period, addition observing impact COVID-19 pandemic on possible reduction SUS after year 2020. Methodology: It is retrospective, cross-sectional, descriptive available records Health Centers linked Unified System, including data collection regarding Brazil. Data were extracted DATASUS....

10.29289/259453942024v34s1040 article EN Mastology 2024-01-01

Objective: Receptor tyrosine kinases (RTKs) are involved in cell growth, motility, and differentiation. Deregulation of RTK signaling is associated with tumor development therapy resistance. Potential RTKs such as TAM (TYRO3, AXL, MERTK), RON, EPH, MET have been evaluated many cancers lung, prostate, colorectal, but less known breast tumors. In this study, 51 luminal cancer tissue 8 triple-negative (TNBC) subtypes were by qPfor the expression TAM, EPHA2, genes. Methodology: The study was...

10.29289/259453942024v34s1075 article EN Mastology 2024-01-01

Objectives: The objective of the study was to compare postoperative staging and clinical development outcomes in a period three years with histopathological immunohistochemical characteristics considered prognostic and/or predictive factors patients being treated for triple negative type breast cancer Barão Lucena Hospital, Recife, Pernambuco.Method: conducted 125 female suffering from who underwent surgical treatment mastology service Hospital 2009 2012.The pathological features tumors were...

10.29289/z2594539420170000228 article EN Mastology 2017-12-01
Coming Soon ...